ACUTA CAPITAL PARTNERS, LLC
Q4 2024 13F Holdings
- Locationredwood city, CA
- Num holdings
39
- Value ($000)
$99,404
- Date Filed02/14/2025
- Form type13F-HR
- CIK0001582844
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
---|---|---|---|---|---|---|---|
OCUL OCULAR THERAPEUTIX INC | COM | 67576A100 | $9.49M | 10 % | 1,111,071 | ||
INSM INSMED INC | COM PAR $.01 | 457669307 | $7.24M | 7 % | 104,800 | ||
TOURMALINE BIO INC | COM | 89157D105 | $7.14M | 7 % | 351,842 | ||
CRNX CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | $6.28M | 6 % | 122,900 | ||
ELVN ENLIVEN THERAPEUTICS INC | COM | 29337E102 | $6.02M | 6 % | 267,368 | ||
AADI AADI BIOSCIENCES INC | COM | 00032Q104 | $5.83M | 6 % | 1,849,402 | ||
PRAX PRAXIS PRECISION MEDICINES I | COM | 74006W207 | $5.19M | 5 % | 67,500 | ||
RVMD REVOLUTION MEDICINES INC | COM | 76155X100 | $4.89M | 5 % | 111,700 | ||
ARGX ARGENX SE | SPONSORED ADR | 04016X101 | $4.25M | 4 % | 6,910 | ||
PCVX VAXCYTE INC | COM | 92243G108 | $3.68M | 4 % | 45,000 |
Rows Per Page
1 - 10 of 3910
- 10
- 50
- 100